Post-IPO Equity Biotechnology Companies

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

Imugene is a publicly-listed biotechnology company with operations in America and Europe,

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

Grey Matters Health company is focused on developing, in-licensing, and commercializing proprietary innovative.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

A health sciences company that develops innovative options for preventive and curative therapies .

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Shortwave Life Sciences is a biotech company that develops psychedelics-based medicine.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Forte Biosciences is a biotechnology company that focuses on dermatology.

PMGC is a biotechnology company that develops regenerative skin care applications.

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.

Nanollose is a research and development company, specialising in the development of Plant-Free cellulose technologies.

Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.

Cube Labs is the first systematic venture builder in the healthcare technology space in Italy.

Mountain Valley MD Holdings is in the final stages of proving up a low-cost, low-risk exploration project.